Signal active
Organization
Contact Information
Overview
Elaborate eliminates one of the top two leading causes of doctor burnout and churn: the inbasket. Our award-winning clinical technology is the leading software used by health systems to eliminate Inbasket messaging challenges.
Embedded in both the practitioner EMR and patient portal, Elaborate is the only solution on the market that takes a preventive approach to the inbox, putting an end to panicked patient messages and hours of admin time weekly for practitioners.
By leveraging our proprietary deterministic clinical ruleset, over 90% of Elaborate's narratives require no edits by clinician users. Within weeks of launch, expect a 36% reduction in in-basket time for practitioners and a remarkable 92% patient satisfaction rate.
Elaborate is responsible for millions of patient lives and has been validated across millions of live patient interactions.
About
Enterprise Software, Software, Health Care, Medical, Health Diagnostics
2021
11-50
Headquarters locations
New York, New York, United States, North America
Social
N/A
Profile Resume
Elaborate headquartered in New York, New York, United States, North America, operates in the Enterprise Software, Software, Health Care, Medical, Health Diagnostics sector. The company focuses on Enterprise Software and has secured $757.5M in funding across 60 round(s). With a team of 11-50 employees, Elaborate is actively contributing to advancements in Enterprise Software. Their latest funding round, Seed Round - Elaborate, raised $100.0K. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
3
1
0
$12.6M
Details
3
Elaborate has raised a total of $12.6M in funding over 3 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2021 | Seed | 2.5M | ||
2023 | Seed | 10.0M | ||
2024 | Seed | 100.0K |
Investors
Elaborate is funded by 19 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Elliot Cohen | - | FUNDING ROUND - Elliot Cohen | 10.0M |
Nirdesh Gupta | - | FUNDING ROUND - Nirdesh Gupta | 100.0K |
Elaborate | - | FUNDING ROUND - Elaborate | 100.0K |
Cedars-Sinai Accelerator | - | FUNDING ROUND - Cedars-Sinai Accelerator | 100.0K |
Recent Activity
There is no recent news or activity for this profile.